{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:59:53Z","timestamp":1781755193006,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cca.2023.117372","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T19:51:24Z","timestamp":1682797884000},"page":"117372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy"],"prefix":"10.1016","volume":"545","author":[{"given":"Weili","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qipan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6181-4548","authenticated-orcid":false,"given":"Qunli","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2023.117372_b0005","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2016.01.021","article-title":"Thoracic lymphadenopathy in benign diseases: A state of the art review","volume":"112","author":"Nin","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2023.117372_b0010","doi-asserted-by":"crossref","unstructured":"M.A. Judson, B.W. Thompson, D.L. Rabin, J. Steimel, G.L. Knattereud, D.T. Lackland, C. Rose, C.S. Rand, R.P. Baughman, A.S. Teirstein, A.R. Group, The diagnostic pathway to sarcoidosis, Chest 123(2) (2003) 406\u2013412.","DOI":"10.1378\/chest.123.2.406"},{"key":"10.1016\/j.cca.2023.117372_b0015","doi-asserted-by":"crossref","unstructured":"U. Costabel, G.W. Hunninghake, ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders, Eur. Respir. J. 14(4) (1999) 735\u2013737.","DOI":"10.1034\/j.1399-3003.1999.14d02.x"},{"issue":"5","key":"10.1016\/j.cca.2023.117372_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"The Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","author":"Statement on sarcoidosis","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5261","key":"10.1016\/j.cca.2023.117372_b0030","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br. Med. J."},{"key":"10.1016\/j.cca.2023.117372_b0035","doi-asserted-by":"crossref","unstructured":"S.H. Wang, C.H. Chung, T.W. Huang, W.C. Tsai, C.K. Peng, K.L. Huang, W.C. Perng, C.F. Chian, W.C. Chien, C.H. Shen, Bidirectional association between tuberculosis and sarcoidosis, Respirology (Carlton, Vic.) 24(5) (2019) 467-474.","DOI":"10.1111\/resp.13482"},{"issue":"6","key":"10.1016\/j.cca.2023.117372_b0040","first-page":"6166","article-title":"Development of a random forest model to classify sarcoidosis and tuberculosis","volume":"13","author":"Ma","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102462","article-title":"Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: An Immunopathogenic perspective","volume":"19","author":"Tarasidis","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.cca.2023.117372_b0050","doi-asserted-by":"crossref","unstructured":"R. Kraaijvanger, M. Janssen Bon\u00e1s, A.D.M. Vorselaars, M. Veltkamp, Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects, Front. Immunol. 11 (2020) 1443.","DOI":"10.3389\/fimmu.2020.01443"},{"key":"10.1016\/j.cca.2023.117372_b0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev.immunol.26.021607.090357","article-title":"The biology of interleukin-2","volume":"26","author":"Malek","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cca.2023.117372_b0060","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1378\/chest.98.5.1125","article-title":"Serum concentration of soluble interleukin-2 receptor as a sensitive parameter of disease activity in sarcoidosis","volume":"98","author":"Keicho","year":"1990","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0065","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.cca.2023.117372_b0070","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1378\/chest.124.1.186","article-title":"Serum soluble interleukin-2 receptor measurement in patients with sarcoidosis: a clinical evaluation","volume":"124","author":"Grutters","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cca.2023.117372_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2020.106115","article-title":"sIL-2R concentrations predict the spontaneous remission in sarcoidosis","volume":"171","author":"Zhou","year":"2020","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.cca.2023.117372_b0080","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.cca.2023.117372_b0085","doi-asserted-by":"crossref","first-page":"667","DOI":"10.5858\/134.5.667","article-title":"Granulomatous lung disease: an approach to the differential diagnosis","volume":"134","author":"Mukhopadhyay","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"5 Suppl","key":"10.1016\/j.cca.2023.117372_b0095","doi-asserted-by":"crossref","first-page":"e211S","DOI":"10.1378\/chest.12-2355","article-title":"Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Silvestri","year":"2013","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1378\/chest.13-2339","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis","volume":"146","author":"Gupta","year":"2014","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1164\/rccm.201203-0393OC","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial","volume":"186","author":"Navani","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cca.2023.117372_b0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13000-020-00958-4","article-title":"Comparison of transbronchial needle aspiration with and without ultrasound guidance for diagnosing benign lymph node adenopathy","volume":"15","author":"Shen","year":"2020","journal-title":"Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.cca.2023.117372_b0115","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3904\/kjim.2013.28.6.660","article-title":"The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool","volume":"28","author":"Choi","year":"2013","journal-title":"Korean J. Intern. Med."},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1378\/chest.08-2768","article-title":"A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis","volume":"136","author":"Tremblay","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.cca.2023.117372_b0125","doi-asserted-by":"crossref","unstructured":"N. Navani, H.L. Booth, G. Kocjan, M. Falzon, A. Capitanio, J.M. Brown, J.C. Porter, S.M. Janes, Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis, Respirology (Carlton, Vic.) 16(3) (2011) 467-472.","DOI":"10.1111\/j.1440-1843.2011.01933.x"},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0130","first-page":"61","article-title":"Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases","volume":"13","author":"Belli","year":"2000","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0135","first-page":"102","article-title":"Soluble interleukin-2 receptor in blood from patients with sarcoidosis and idiopathic pulmonary fibrosis","volume":"11","author":"Tsutsumi","year":"1994","journal-title":"Sarcoidosis"},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/biom8030084","article-title":"YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity","volume":"8","author":"Uysal","year":"2018","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.cca.2023.117372_b0145","doi-asserted-by":"crossref","first-page":"e0223897","DOI":"10.1371\/journal.pone.0223897","article-title":"Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis","volume":"14","author":"Eurelings","year":"2019","journal-title":"PLoS one"},{"issue":"7","key":"10.1016\/j.cca.2023.117372_b0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expert Rev. Respir. Med."},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.cca.2023.117372_b0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0165","first-page":"185","article-title":"Biochemical markers in sarcoidosis","volume":"24","author":"Selroos","year":"1986","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.cca.2023.117372_b0170","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","article-title":"Elevation of serum angiotensin-converting-enzyme (ACE) concentration in sarcoidosis","volume":"59","author":"Lieberman","year":"1975","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.cca.2023.117372_b0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.amjms.2022.12.001","article-title":"Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease","volume":"365","author":"Wu","year":"2023","journal-title":"Am. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.cca.2023.117372_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MD.0b013e3181d5c6b4","article-title":"Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study","volume":"89","author":"Cohen-Aubart","year":"2010","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.cca.2023.117372_b0185","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1378\/chest.09-1975","article-title":"Comparative evaluation of serum markers in pulmonary sarcoidosis","volume":"137","author":"Miyoshi","year":"2010","journal-title":"Chest"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:08:33Z","timestamp":1757862513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123001742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":37,"alternative-id":["S0009898123001742"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117372","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical diagnostic value of serum soluble IL-2 receptor for stage I sarcoidosis in benign isolated mediastinal and hilar lymphadenopathy","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117372"}}